Amsurg Corp. (NASDAQ:AMSG) rose 2.9% during mid-day trading on Monday . The stock traded as high as $65.58 and last traded at $65.44, with a volume of 611,493 shares. The stock had previously closed at $63.60.

AMSG has been the subject of a number of research analyst reports. Bank of America Corp. upgraded Amsurg Corp. from a “neutral” rating to a “buy” rating and set a $104.00 price target for the company in a report on Thursday, June 16th. Jefferies Group reiterated a “buy” rating on shares of Amsurg Corp. in a report on Sunday, July 3rd. Citigroup Inc. downgraded Amsurg Corp. from a “buy” rating to a “neutral” rating in a report on Thursday, June 16th. Wells Fargo & Co. initiated coverage on Amsurg Corp. in a report on Tuesday, June 14th. They issued a “market perform” rating for the company. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $95.00 price target on shares of Amsurg Corp. in a report on Thursday, July 14th. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $93.91.

The stock has a 50-day moving average price of $71.02 and a 200 day moving average price of $74.20. The firm has a market capitalization of $3.46 billion and a P/E ratio of 19.12.

Amsurg Corp. (NASDAQ:AMSG) last announced its earnings results on Tuesday, August 2nd. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.02. The business had revenue of $758.50 million for the quarter, compared to the consensus estimate of $769.88 million. Amsurg Corp.’s revenue for the quarter was up 21.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.97 EPS. Equities research analysts expect that Amsurg Corp. will post $4.33 earnings per share for the current fiscal year.

In related news, insider Robert Jon Coward sold 7,500 shares of the stock in a transaction that occurred on Thursday, August 18th. The stock was sold at an average price of $64.36, for a total transaction of $482,700.00. Following the completion of the sale, the insider now owns 105,007 shares in the company, valued at approximately $6,758,250.52. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

A hedge fund recently raised its stake in Amsurg Corp. stock. Dimensional Fund Advisors LP boosted its stake in shares of Amsurg Corp. (NASDAQ:AMSG) by 3.2% during the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 2,994,029 shares of the company’s stock after buying an additional 92,088 shares during the period. Dimensional Fund Advisors LP owned approximately 6.27% of Amsurg Corp. worth $227,552,000 at the end of the most recent quarter.

AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.